TGFB1 and head and neck squamous cell carcinoma: In freshly purified patient and healthy NK cell control experiments, the human HNSCC cell line SCC-4 (ATCC: CRL-1624) showed synergistic inhibition of NKG2D expression under the action of multiple factors, especially TGF-β1 (44).